FMC Corp lands in Perpignan the week of its strategic review

FMC Corp flew from Brussels to Perpignan on May 22, a 92-minute hop in its Challenger 605 that landed near the company's European research and development center in the south of France. The trip comes just days after FMC Corp priced $1.2 billion in senior secured notes, per an SEC filing on May 21, part of a broader effort to refinance debt and fund operations while the board weighs a potential sale.

The same week, FMC Corp's chairman and CEO Pierre Brondeau is overseeing a company in flux: the board authorized a strategic alternatives review in February, including a possible sale, as the agricultural sciences firm battles generic competition and a weak farm economy, the Philadelphia Inquirer reported in March. The Perpignan site is central to FMC Corp's innovation pipeline, which Brondeau has described as key to returning to growth by 2027.

This flight follows a pattern of European travel for FMC Corp's leadership: the aircraft visited Barcelona on May 16 and Brussels on May 21, likely for meetings tied to the company's ongoing cost-cutting program, Project Foundation, and its push to register new active ingredients like Isoflex in the EU.